Nektar boosts authorized shares to 390M, completes 1-for-15 reverse split effective June 8

NEKTAR THERAPEUTICS

Authorized common shares increased from 300M to 390M, effective June 6, 2025, stockholder-approved May 23, 2025.
Reverse stock split at 1-for-15 ratio effective 11:59 p.m. ET June 8; split-adjusted trading starts June 9 under NKTR.
Fractional shares rounded up at DTC for directly held shares; rounded down to nearest whole share for equity awards.
Total authorized shares remain at 390M after reverse split due to prior increase.

item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.